Tumor-targeting oncolytic virus elicits potent immunotherapeutic vaccine responses to tumor antigens.
Luo Y, Lin C, Zou Y, Ju F, Ren W, Lin Y, Wang Y, Huang X, Liu H, Yu Z, Liu P, Tan G, Yuan Q, Zhang J, Huang C, Xia N.
Luo Y, et al.
Oncoimmunology. 2020 Feb 12;9(1):1726168. doi: 10.1080/2162402X.2020.1726168. eCollection 2020.
Oncoimmunology. 2020.
PMID: 32117591
Free PMC article.